News

Hookipa is awarded a grant from the Austrian Research Promotion Agency

Vienna (Austria), September 18, 2012 - Hookipa Biotech AG, an Austrian based biotech company today announced the award…

Intercell announces Phase I results on its Vaccine Enhancement Patch (VEP) with Pandemic Influenza antigens

•The co-administration of an A/H5N1 antigen via intramuscular administration (IM) with VEP met two of three CHMP…

Mediatum Top-Management-Studie 2012

Sorry, this entry is only available in German!

SANOCHEMIA - Synthetisches Galantamin für den Weltmarkt

Sorry, this entry is only available in German!

Pharmig: Medizinischer Fortschritt braucht Forschung

Sorry, this entry is only available in German!

GMI: Pflanzenforschung: Genomstabilität in Ei- und Spermazellen

Sorry, this entry is only available in German!

LISAvienna News

Celebrating ten years of LISAvienna - the Vienna Life Science Cluster!

Ten years of successful progress: Life Sciences in Vienna

Intercell’s partner Biological E. Ltd. launches Japanese Encephalitis vaccine JEEV® in India

» Novel vaccine to protect children and adults from Japanese Encephalitis (JE), manufactured by partner Biological E.…

IMP: The Biology of Emotions

Neurobiologist Wulf Haubensak, Group Leader at the Research Institute of Molecular Pathology (IMP) in Vienna, has been…

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.